A Phase II Open Label Study of BMS-582664 in Locally Advanced or Metastatic Hepatocellular Cancer
Status:
Completed
Trial end date:
2010-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this clinical research study is to learn if BMS-582664 can shrink or slow the
growth of advanced liver cancer. The safety of this treatment will also be studied.